Alban Fabre

Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor–Defined Invasive Breast Cancer

A. Fournier, Alban Fabre, Sylvie Mesrine et al. · Journal of Clinical Oncology · 2008 · 179 citations · Full text

Medicine, Endocrinology, Oncology +15

Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European Prospective Investigation into Cancer and Nutrition

Kjersti Bakken, A. Fournier, Eiliv Lund et al. · International Journal of Cancer · 2010 · 138 citations · Full text

Medicine, Endocrinology, Oncology +17

Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women

Marie‐Christine Boutron‐Ruault, Alban Fabre, Françoise Clavel‐Chapelon et al. · American Journal of Clinical Nutrition · 2008 · 100 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)

Lamiae Grimaldi‐Bensouda, Frédéric Rouillon, Bernard Astruc et al. · Schizophrenia Research · 2011 · 90 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer

Évanguelos Xylinas, Guillaume Ploussard, Xavier Durand et al. · British Journal of Urology · 2010 · 53 citations

Medicine, Surgery, Urology +17